Compugen Ltd. (CGEN)
1.68
+0.01
(+0.60%)
USD |
NASDAQ |
Feb 09, 10:15
Compugen EPS Diluted (Quarterly) : -0.0746 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Teva Pharmaceutical Industries Ltd. | 0.4118 |
| Kamada Ltd. | 0.0918 |
| Pluri, Inc. | -0.6503 |
| BioLineRx Ltd. | -0.223 |
| XTL Biopharmaceuticals Ltd. | -0.0292 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.979M |
| Revenue (Quarterly) | 1.891M |
| Total Expenses (Quarterly) | 8.87M |
| Enterprise Value | 73.06M |
| Gross Profit Margin (Quarterly) | 12.74% |
| Profit Margin (Quarterly) | -369.1% |
| Earnings Yield | -17.81% |
| Normalized Earnings Yield | -17.81 |